The influence of comorbidity on mortality in ovarian cancer patients

Gynecologic Oncology

Volumn 133, Issue 2, 2014, Pages 298-303

  Stalberg K ^a   Svensson, T ^b   Lonn S ^b,c   Kieler, H ^b  

^a UPPSALA UNIVERSITY   (Sweden)

^b KAROLINSKA INSTITUTE   (Sweden)

^c Research and Development Region Hall and   (Sweden)

Author keywords

Comorbidity; Epidemiology; Mortality; Ovarian cancer

Indexed keywords

ADULT; AGED; ARTICLE; CANCER DIAGNOSIS; CANCER MORTALITY; CANCER PATIENT; CANCER REGISTRY; CAUSE OF DEATH; COMORBIDITY; CONTROLLED STUDY; DIABETES MELLITUS; FEMALE; HEMATOLOGIC DISEASE; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; OVARY CANCER; POPULATION RESEARCH; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; THROMBOEMBOLISM; VERY ELDERLY;

COMORBIDITY; EPIDEMIOLOGY; MORTALITY; OVARIAN CANCER;

AGED; COMMUNICABLE DISEASES; COMORBIDITY; DIABETES MELLITUS; FEMALE; HEMATOLOGIC DISEASES; HUMANS; HYPERTENSION; MIDDLE AGED; NEOPLASMS, GERM CELL AND EMBRYONAL; NEOPLASMS, GLANDULAR AND EPITHELIAL; OVARIAN NEOPLASMS; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; RISK FACTORS; SARCOMA; SEX CORD-GONADAL STROMAL TUMORS; SWEDEN; THROMBOEMBOLISM;

EID: 84899638961     PISSN: 00908258     EISSN: 10956859     Source Type: Journal    
DOI: 10.1016/j.ygyno.2014.02.024     Document Type: Article

References (26)

1. A. Bakhru, R.J. Buckanovich, and J.J. Griggs The impact of diabetes on survival in women with ovarian cancer Gynecol Oncol 121 2011 106 111
2. L. Barlow, K. Westergren, L. Holmberg, and M. Talback The completeness of the Swedish Cancer Register: a sample survey for year 1998 Acta Oncol 48 2009 27 33
3. A. Berglund, H. Garmo, C. Tishelman, L. Holmberg, P. Stattin, and M. Lambe Comorbidity, treatment and mortality: a population based cohort study of prostate cancer in PCBaSe Sweden J Urol 185 2011 833 839
4. T. Bjorge, A. Engeland, S. Hansen, and C.G. Trope Prognosis of patients with ovarian cancer and borderline tumours diagnosed in Norway between 1954 and 1993 Int J Cancer 75 1998 663 670
5. N.G. Cloven, A. Manetta, M.L. Berman, M.F. Kohler, and P.J. DiSaia Management of ovarian cancer in patients older than 80 years of Age Gynecol Oncol 73 1999 137 139
6. L.M. Elit, S.J. Bondy, L.P. Paszat, E.J. Holowaty, G.M. Thomas, and T.A. Stukel et al. Surgical outcomes in women with ovarian cancer Can J Surg 51 2008 346 354
7. G.F.J. Engholm, N. Christensen, F. Bray, Marianne L. Gjerstorff, Å. Klint, and Jóanis E. Køtlum et al. NORDCAN: Cancer incidence, mortality, prevalence and prediction in the Nordic countries 2010 Danish Cancer Society
8. A.N. Fader, V. von Gruenigen, H. Gibbons, F. Abushahin, D. Starks, and M. Markman et al. Improved tolerance of primary chemotherapy with reduced-dose carboplatin and paclitaxel in elderly ovarian cancer patients Gynecol Oncol 109 2008 33 38
9. J.S. Ferriss, K. Ring, E.R. King, M. Courtney-Brooks, L.R. Duska, and P.T. Taylor Does significant medical comorbidity negate the benefit of up-front cytoreduction in advanced ovarian cancer? Int J Gynecol Cancer 22 2012 762 769
10. G. Freyer, N. Jovenin, G. Yazbek, C. Villanueva, A. Hussain, and A. Berthune et al. Granocyte-colony stimulating factor (G-CSF) has significant efficacy as secondary prophylaxis of chemotherapy-induced neutropenia in patients with solid tumors: results of a prospective study Anticancer Res 33 2013 301 307
11. K. Fust, X. Li, M. Maschio, R. Barron, M.C. Weinstein, and A. Parthan et al. Cost-effectiveness of prophylaxis treatment strategies for febrile neutropenia in recurrent ovarian cancer patients Value Health 16 2013 A140
12. A. Klint, L. Tryggvadottir, F. Bray, M. Gislum, T. Hakulinen, and H.H. Storm et al. Trends in the survival of patients diagnosed with cancer in female genital organs in the Nordic countries 1964-2003 followed up to the end of 2006 Acta Oncol 49 2010 632 643
13. G.H. Lyman, A.A. Khorana, N.M. Kuderer, A.Y. Lee, J.I. Arcelus, and E.P. Balaban et al. Venous thromboembolism prophylaxis and treatment in patients with cancer: American society of clinical oncology clinical practice guideline update J Clin Oncol 31 2013 2189 2204
14. H.A. Maas, R.F. Kruitwagen, V.E. Lemmens, S.H. Goey, and M.L. Janssen-Heijnen The influence of age and co-morbidity on treatment and prognosis of ovarian cancer: a population-based study Gynecol Oncol 97 2005 104 109
15. M. Markman, J.L. Lewis Jr., P. Saigo, T. Hakes, S. Rubin, and W. Jones et al. Impact of age on survival of patients with ovarian cancer Gynecol Oncol 49 1993 236 239
16. A. Olaitan, A. Mocroft, and I. Jacobs Patterns in the incidence of age-related ovarian cancer in South East England 1967-1996 BJOG 107 2000 1094 1096
17. L.A. Ries Ovarian cancer. Survival and treatment differences by age Cancer 71 1993 524 529
18. A.O. Rodriguez, T. Wun, H. Chew, H. Zhou, D. Harvey, and R.H. White Venous thromboembolism in ovarian cancer Gynecol Oncol 105 2007 784 790
19. R.J. Sheppard, J. Berger, and I.A. Sebag Cardiotoxicity of cancer therapeutics: current issues in screening, prevention, and therapy Front Pharmacol 4 2013 19
20. K.J. Shrum, S.E. Gill, L.K. Thompson, D.W. Blackhurst, and L.E. Puls New-onset congestive heart failure with gemcitabine in ovarian and other solid cancers Am J Clin Oncol 2013 [in press] 10.1097/COC.0b013e31827b459a
21. L.A. Smith, V.R. Cornelius, C.J. Plummer, G. Levitt, M. Verrill, and P. Canney et al. Cardiotoxicity of anthracycline agents for the treatment of cancer: systematic review and meta-analysis of randomised controlled trials BMC Cancer 10 2010 337
22. K. Stalberg, T. Svensson, F. Granath, H. Kieler, B. Tholander, and S. Lonn Evaluation of prevalent and incident ovarian cancer co-morbidity Br J Cancer 106 2012 1860 1865
23. H.H. Storm, G. Engholm, T. Hakulinen, L. Tryggvadottir, A. Klint, and M. Gislum et al. Survival of patients diagnosed with cancer in the Nordic countries up to 1999-2003 followed to the end of 2006. A critical overview of the results Acta Oncol 49 2010 532 544
24. S. Tateo, L. Mereu, S. Salamano, C. Klersy, M. Barone, and A.C. Spyropoulos et al. Ovarian cancer and venous thromboembolic risk Gynecol Oncol 99 2005 119 125
25. M.S. Tetsche, M. Norgaard, J. Jacobsen, P. Wogelius, and H.T. Sorensen Comorbidity and ovarian cancer survival in Denmark, 1995-2005: a population-based cohort study Int J Gynecol Cancer 18 2008 421 427
26. S. Tingulstad, F.E. Skjeldestad, T.B. Halvorsen, and B. Hagen Survival and prognostic factors in patients with ovarian cancer Obstet Gynecol 101 2003 885 891